Leading the fight against diabetes

Defeating diabetes is the aspiration anchored in Novo Nordisk’s vision. It is more than a business proposition – it is the main driver for the company’s contribution to sustainable development. Taking responsibility for tackling this chronic diease – one of four that together account for 50% of global mortality – Novo Nordisk’s mission is to be leading the fight agaist diabetes.

A global perspective

Good health is a driver of economic growth. That is why the pharmaceutical industry has a particular responsibility to help provide health for all, which is a universal human right. In doing so, it can also contribute to sustainable development in a global perspective.

On the mission to defeat diabetes Novo Nordisk is working in partnerships towards common goals of prevention, detection and treatment.

It’s all about people with diabetes

The key objective is to serve people with diabetes and to help them gain maximum control of their condition, enabling them to lead full and rich lives despite having diabetes.
Diabetes is more than just a disease. Novo Nordisk recognises the person behind the disease and believes that the key to improved treatment and quality of life lies in learning from those affected by it, be it people with diabetes, their families, caretakers and healthcare professionals.

Taking action to defeat diabetes

Working in and with the diabetes communities, Novo Nordisk contributes to raising awareness and providing education about diabetes – how to live with it and how to offset or even prevent it. See "Can diabetes really be defeated?"

Let’s learn from young people

Novo Nordisk seeks to learn from those who know what it is like living with diabetes. The aim is to help create a future in which the epidemic growth of diabetes can be curbed and people may be able to manage their diabetes, getting on with their lives.
See how in "Getting on with my life".
To really make an impact on society’s health, attention needs to be focused on the future generation. That is why Novo Nordisk is engaging with young people with diabetes around the world, to learn from and get inspired by them.

  •  

Stock exchange announcement

Full year results 2004
  •  
  •  

Case stories

Results with stakeholders
  •  
  •  
Annual Report 2004
  •